Michael W Schwartz Selected Research

Fibroblast Growth Factor 1 (FGF-1)

1/2022	Combined micro-osmotic pump infusion and intracerebroventricular injection to study FGF1 signaling pathways in the mouse brain.
9/2021	Role of hypothalamic MAPK/ERK signaling and central action of FGF1 in diabetes remission.
10/2020	Hypothalamic perineuronal net assembly is required for sustained diabetes remission induced by fibroblast growth factor 1 in rats.
1/2020	Transcriptomic analysis links diverse hypothalamic cell types to fibroblast growth factor 1-induced sustained diabetes remission.
1/2019	The Hypothalamic Arcuate Nucleus-Median Eminence Is a Target for Sustained Diabetes Remission Induced by Fibroblast Growth Factor 1.
1/2019	Peripheral Mechanisms Mediating the Sustained Antidiabetic Action of FGF1 in the Brain.
1/2016	Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael W Schwartz Research Topics

Disease

41	Obesity 01/2021 - 01/2003
27	Insulin Resistance 01/2022 - 10/2005
24	Body Weight (Weight, Body) 01/2019 - 03/2002
16	Weight Gain 01/2017 - 02/2003
14	Inflammation (Inflammations) 08/2015 - 10/2005
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2010
13	Weight Loss (Weight Reduction) 10/2017 - 06/2003
12	Hyperglycemia 01/2022 - 01/2006
11	Hyperphagia (Overeating) 12/2020 - 03/2002
11	Anorexia 07/2017 - 02/2003
9	AIDS-Related Complex (ARC) 10/2020 - 03/2002
5	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 07/2004
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2005
4	Glucose Intolerance 01/2017 - 10/2012
2	Neoplasms (Cancer) 07/2017 - 10/2012
2	Diabetes Mellitus 11/2015 - 02/2011
2	Morbid Obesity 06/2013 - 03/2005
1	Schizophrenia (Dementia Praecox) 11/2019
1	Hyperthermia 01/2019
1	Nausea 03/2015
1	Diarrhea 03/2015
1	Metabolic Diseases (Metabolic Disease) 12/2014
1	Atherosclerosis 12/2014
1	Starvation 09/2014

Drug/Important Bio-Agent (IBA)

34	Insulin (Novolin)FDA Link 01/2022 - 01/2003
31	LeptinIBA 01/2019 - 03/2002
27	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2002
8	Hormones (Hormone)IBA 01/2014 - 05/2002
8	Messenger RNA (mRNA)IBA 06/2010 - 03/2002
7	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2022 - 01/2016
7	Leptin ReceptorsIBA 01/2012 - 05/2003
6	PalmitatesIBA 10/2014 - 06/2007
5	MelanocortinsIBA 01/2017 - 03/2002
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015 - 08/2005
4	Blood Glucose (Blood Sugar)IBA 01/2021 - 07/2010
4	Peptides (Polypeptides)IBA 12/2020 - 03/2002
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 11/2013
4	Oxytocin (Pitocin)FDA LinkGeneric 10/2017 - 01/2012
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2017 - 03/2002
4	LipidsIBA 12/2014 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 09/2014 - 06/2007
4	Neuropeptide YIBA 09/2006 - 03/2002
3	CorticosteroneIBA 12/2018 - 07/2004
3	Streptozocin (Streptozotocin)FDA Link 11/2015 - 10/2004
3	fibroblast growth factor 21IBA 08/2015 - 07/2010
3	Biological ProductsIBA 12/2014 - 12/2004
3	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2014 - 12/2006
3	Phosphotransferases (Kinase)IBA 10/2012 - 12/2005
3	CytokinesIBA 07/2010 - 11/2007
3	NF-KappaB Inhibitor alphaIBA 06/2010 - 11/2008
3	NF-kappa B (NF-kB)IBA 04/2010 - 06/2007
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2010 - 01/2003
3	LipopolysaccharidesIBA 12/2009 - 06/2003
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 08/2015
2	EnzymesIBA 01/2019 - 12/2005
2	Glucagon (Glukagon)FDA Link 12/2018 - 07/2004
2	Protein Isoforms (Isoforms)IBA 01/2017 - 05/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2015 - 04/2010
2	Lipase (Acid Lipase)FDA Link 04/2015 - 03/2010
2	vasodilator-stimulated phosphoproteinIBA 10/2014 - 11/2011
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2011 - 11/2011
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2011 - 04/2010
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 06/2011 - 06/2011
2	Insulin ReceptorIBA 05/2011 - 04/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2011 - 02/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 09/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2010 - 09/2009
2	EndotoxinsIBA 12/2009 - 11/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2007 - 02/2006
2	GhrelinIBA 10/2004 - 07/2002
1	Polysaccharides (Glycans)IBA 01/2022
1	chondroitin sulfate glycosaminoglycanIBA 01/2022
1	GlycosaminoglycansIBA 10/2020
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 10/2020
1	DisaccharidesIBA 11/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	GlucokinaseIBA 01/2019
1	Calcitonin Gene-Related PeptideIBA 07/2017
1	Protein Kinase CIBA 01/2017
1	PKC-3 proteinIBA 01/2017
1	pyrrolidonyl-beta-naphthylamideIBA 04/2016
1	Transcription Factors (Transcription Factor)IBA 04/2016
1	Steroidogenic Factor 1IBA 04/2016
1	cholecystokinin 8IBA 04/2016
1	GlucocorticoidsIBA 11/2015
1	LigandsIBA 08/2015
1	PD 173074IBA 08/2015
1	Serine (L-Serine)FDA Link 04/2015
1	Alanine (L-Alanine)FDA Link 04/2015
1	FructoseIBA 03/2015
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2014
1	CalciumIBA 01/2014
1	AdipokinesIBA 01/2014

Therapy/Procedure

5	Therapeutics 01/2021 - 09/2010
2	Fat-Restricted Diet (Diet, Fat Restricted) 10/2014 - 04/2010
2	Bariatric Surgery 06/2011 - 06/2011
2	Intraventricular Infusions 07/2010 - 09/2005
1	Transplantation 08/2015
1	Injections 03/2015
1	Ketogenic Diet 09/2014